gefitinib,tepotinib,pembrolizumab
astrazeneca,immutep,merck
['ease,(-please),(-disease),(-incrrease),(-decrease)', 'insight,(-insights)', 'immutep']
$imm immutep (asx:imm) released a price sensitive announcement to the asx: insight-003 triple combination data presented at sitc 2022 it is ranked as the 517th most shorted stock as per latest data (3-nov) #ausbiz #asx #markets 